In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 2, 2001, Pages 150-151

  Vazquez J A ^a   Berron S ^a   Gimenez M J ^b   De la Fuente, L ^a   Aguilar, L ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G; RIFAMPICIN; SULFADIAZINE; TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BINDING AFFINITY; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0035079289     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011248     Document Type: Article

References (8)

1. Comparative evaluation of Etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents
2. Update on meningococcal disease with emphasis on pathogenesis and clinical management
3. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: A 5-year history (1985-1989)
4. Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci
5. Increase in moderate penicillin resistance and serogroup C in meningococcal strains isolated in Spain. Is there any relationship?
6. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin
7. Efficacy of BMS 284756 (BMS) against penicillin-sensitive, penicillin- and quinolone-resistant pnemococci in the experimental meningitis model
8. Gemifloxacin is effective in experimental pneumococcal meningitis